September 26, 2024
Immunai signs $18M collaboration with AstraZeneca to make cancer drug trials more efficient
Get access to detailed funding analysis, investor insights, company intelligence, and much more
Round size percentiles, market activity, sector trends
Growth stage analysis, funding history, investor quality
Export data, save to watchlist, share analysis
Join thousands of investors, founders, and analysts who rely on Seedtable's intelligence platform